Drug Shortage Report for DILANTIN-30 SUSPENSION
| Report ID | 76444 |
| Drug Identification Number | 00023442 |
| Brand name | DILANTIN-30 SUSPENSION |
| Common or Proper name | DILANTIN-30 SUSPENSION |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PHENYTOIN |
| Strength(s) | 30MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 250ML |
| ATC code | N03AB |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-05-23 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2019-05-06 |
| Shortage status | Avoided shortage |
| Updated date | 2019-05-07 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.